name,category,terms5-hydroxytryptamine (serotonin) receptor 1D,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000431$IPR000505:5-Hydroxytryptamine 1D receptor, 450001978$IPR002231:5-Hydroxytryptamine receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
5-hydroxytryptamine (serotonin) receptor 1D,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
5-hydroxytryptamine (serotonin) receptor 1D,PIR_SUPERFAMILY[630005396$PIRSF005474:5-hydroxytryptamine receptor 1, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
5-hydroxytryptamine (serotonin) receptor 1D,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
5-hydroxytryptamine (serotonin) receptor 1D,UP_SEQ_FEATURE[850002194$chain:5-hydroxytryptamine receptor 1D, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,INTERPRO[450001412$IPR001590:Peptidase M12B, ADAM/reprolysin, 450001561$IPR001762:Blood coagulation inhibitor, Disintegrin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002537$IPR002870:Peptidase M12B, propeptide, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450006006$IPR006586:ADAM, cysteine-rich, 450011699$IPR013032:EGF-like region, conserved site, 450016643$IPR018358:Disintegrin, conserved site]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,PIR_SUPERFAMILY[630006703$PIRSF006749:mouse meltrin alpha]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SMART[760000042$SM00050:DISIN, 760000538$SM00608:ACR]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease, 790001405$signal, 790001555$transmembrane, 790001648$zinc, 790001652$zymogen]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,UP_SEQ_FEATURE[850015303$chain:Disintegrin and metalloproteinase domain- containing protein 21, 850102480$compositionally biased region:Cys-rich, 850102585$compositionally biased region:Poly-Val, 850102883$disulfide bond, 850103526$domain:Disintegrin, 850103596$domain:EGF-like, 850104962$domain:Peptidase M12B, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850106245$metal ion-binding site:Zinc; in inhibited form, 850117294$sequence conflict, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
AT hook, DNA binding motif, containing 1,INTERPRO[450016267$IPR017956:AT hook, DNA-binding, conserved site]
AT hook, DNA binding motif, containing 1,SMART[760000336$SM00384:AT_hook]
AT hook, DNA binding motif, containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
AT hook, DNA binding motif, containing 1,UP_SEQ_FEATURE[850002980$chain:A.T hook DNA-binding motif-containing protein 1, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
B-cell CLL/lymphoma 9-like,INTERPRO[450014104$IPR015668:B Cell Lymphoma 9]
B-cell CLL/lymphoma 9-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
B-cell CLL/lymphoma 9-like,UP_SEQ_FEATURE[850007050$chain:B-cell CLL/lymphoma 9-like protein, 850102562$compositionally biased region:Met-rich, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850113605$region of interest:Necessary for interaction with CTNNB1, 850118574$splice variant]
CD247 molecule,BIOCARTA[30000072$h_CSKPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor, 30000075$h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation, 30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000151$h_il17Pathway:IL 17 Signaling Pathway, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents, 30000284$h_tcapoptosisPathway:HIV Induced T Cell Apoptosis, 30000285$h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation, 30000286$h_tcrmolecule:T Cell Receptor and CD3 Complex, 30000287$h_tcrPathway:T Cell Receptor Signaling Pathway, 30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules, 30000299$h_tob1Pathway:Role of Tob in T-cell activation]
CD247 molecule,INTERPRO[450002734$IPR003110:Phosphorylated immunoreceptor signaling ITAM]
CD247 molecule,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway]
CD247 molecule,OMIM_DISEASE[520002611$Immunodeficiency due to defect in CD3-zeta]
CD247 molecule,PIR_SUPERFAMILY[630021605$PIRSF028738:CD3, zeta type]
CD247 molecule,SMART[760000067$SM00077:ITAM]
CD247 molecule,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000733$host-virus interaction, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001481$T-cell receptor, 790001555$transmembrane, 790001556$transmembrane protein]
CD247 molecule,UP_SEQ_FEATURE[850063404$chain:T-cell surface glycoprotein CD3 zeta chain, 850102883$disulfide bond, 850104484$domain:ITAM 1, 850104485$domain:ITAM 2, 850104486$domain:ITAM 3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,INTERPRO[450000537$IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,PIR_SUPERFAMILY[630026222$PIRSF034443:PIRSF034443]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 47,UP_SEQ_FEATURE[850041113$chain:Probable ATP-dependent RNA helicase DDX47, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif, 850118575$strand]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),INTERPRO[450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450005977$IPR006554:Helicase-like, DEXD box c2 type, 450005978$IPR006555:Helicase, ATP-dependent, c2 type, 450009663$IPR010614:DEAD2, 450011687$IPR013020:DNA helicase (DNA repair), Rad3 type, 450012607$IPR014013:Helicase, superfamily 1 and 2, ATP-binding, DinG/Rad3-type]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),PIR_SUPERFAMILY[630023581$PIRSF031023:PIRSF031023]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),SMART[760000433$SM00488:DEXDc2, 760000435$SM00491:HELICc2]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001339$rna-binding]
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 12 (CHL1-like helicase homolog, S. cerevisiae),UP_SEQ_FEATURE[850041102$chain:Probable ATP-dependent RNA helicase DDX12, 850102507$compositionally biased region:Glu-rich, 850104106$domain:Helicase ATP-binding, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117386$short sequence motif:DEAH]
DENN/MADD domain containing 4A,INTERPRO[450001049$IPR001194:DENN, 450002551$IPR002885:Pentatricopeptide repeat, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 4A,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 4A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
DENN/MADD domain containing 4A,UP_SEQ_FEATURE[850008638$chain:C-myc promoter-binding protein, 850102572$compositionally biased region:Poly-Glu, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850106258$modified residue, 850116806$repeat:PPR 1, 850116817$repeat:PPR 2, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal]
DENN/MADD domain containing 5B,INTERPRO[450000897$IPR001024:Lipoxygenase, LH2, 450001049$IPR001194:DENN, 450003532$IPR004012:RUN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 5B,SMART[760000278$SM00308:LH2, 760000527$SM00593:RUN, 760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 5B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
DENN/MADD domain containing 5B,UP_SEQ_FEATURE[850014835$chain:DENN domain-containing protein 5B, 850103503$domain:dDENN, 850103514$domain:DENN, 850105029$domain:PLAT, 850105224$domain:RUN 1, 850105225$domain:RUN 2, 850105606$domain:uDENN, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),INTERPRO[450010027$IPR011084:DNA repair metallo-beta-lactamase]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae),UP_SEQ_FEATURE[850015509$chain:DNA cross-link repair 1A protein, 850106258$modified residue, 850106259$mutagenesis site, 850113804$region of interest:Nuclear focus formation, 850113808$region of interest:Nuclear localization region, 850117295$sequence variant]
DnaJ (Hsp40) homolog, subfamily C, member 16,INTERPRO[450001438$IPR001623:Heat shock protein DnaJ, N-terminal, 450002720$IPR003095:Heat shock protein DnaJ, 450011036$IPR012335:Thioredoxin fold, 450014048$IPR015609:Molecular chaperone, heat shock protein, Hsp40, DnaJ, 450016249$IPR017936:Thioredoxin-like, 450016538$IPR018253:Heat shock protein DnaJ, conserved site]
DnaJ (Hsp40) homolog, subfamily C, member 16,SMART[760000243$SM00271:DnaJ]
DnaJ (Hsp40) homolog, subfamily C, member 16,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
DnaJ (Hsp40) homolog, subfamily C, member 16,UP_SEQ_FEATURE[850016166$chain:DnaJ homolog subfamily C member 16, 850102570$compositionally biased region:Poly-Gln, 850102572$compositionally biased region:Poly-Glu, 850104487$domain:J, 850105478$domain:Thioredoxin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
FGFR1 oncogene partner 2,INTERPRO[450007825$IPR008555:Protein of unknown function DUF837]
FGFR1 oncogene partner 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm]
FGFR1 oncogene partner 2,UP_SEQ_FEATURE[850019347$chain:FGFR1 oncogene partner 2, 850106258$modified residue, 850117294$sequence conflict, 850117881$site:Breakpoint for translocation to form FGFR1OP2-FGFR1, 850118574$splice variant]
FK506 binding protein 2, 13kDa,INTERPRO[450001034$IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type]
FK506 binding protein 2, 13kDa,PIR_SUPERFAMILY[630001631$PIRSF001468:FK506-binding protein 1]
FK506 binding protein 2, 13kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000810$Isomerase, 790000919$membrane, 790001212$polymorphism, 790001343$Rotamase, 790001405$signal]
FK506 binding protein 2, 13kDa,UP_SEQ_FEATURE[850019525$chain:FK506-binding protein 2, 850105058$domain:PPIase FKBP-type, 850105852$helix, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118575$strand, 850118624$turn]
Fas apoptotic inhibitory molecule 2,INTERPRO[450005640$IPR006214:Uncharacterised protein family UPF0005]
Fas apoptotic inhibitory molecule 2,OMIM_DISEASE[520002058$Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity]
Fas apoptotic inhibitory molecule 2,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse, 790001555$transmembrane]
Fas apoptotic inhibitory molecule 2,UP_SEQ_FEATURE[850018981$chain:Fas apoptotic inhibitory molecule 2, 850102581$compositionally biased region:Poly-Ser, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
Fc receptor-like 2,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 2,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 2,UP_SEQ_FEATURE[850019114$chain:Fc receptor-like protein 2, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 61,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 61,PIR_SUPERFAMILY[630030082$PIRSF038578:probable G protein-coupled receptor 61, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 61,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 61,UP_SEQ_FEATURE[850042074$chain:Probable G-protein coupled receptor 61, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
GA binding protein transcription factor, beta subunit 1,INTERPRO[450001870$IPR002110:Ankyrin]
GA binding protein transcription factor, beta subunit 1,PIR_SUPERFAMILY[630027779$PIRSF036345:nuclear respiratory factor-2 beta-1 chain]
GA binding protein transcription factor, beta subunit 1,SMART[760000220$SM00248:ANK]
GA binding protein transcription factor, beta subunit 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
GA binding protein transcription factor, beta subunit 1,UP_SEQ_FEATURE[850020362$chain:GA-binding protein subunit beta-1, 850106259$mutagenesis site, 850114911$region of interest:Transcription activation and HCFC1 interaction, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
GATA binding protein 3,BBID[10000099$78.B_Cell_Development, 10000102$80.T_cell_Activation, 10000111$89.CD4_T_Cell_Differentiation]
GATA binding protein 3,BIOCARTA[30000123$h_GATA3pathway:GATA3 participate in activating the Th2 cytokine genes expression]
GATA binding protein 3,INTERPRO[450000580$IPR000679:Zinc finger, GATA-type, 450011732$IPR013088:Zinc finger, NHR/GATA-type, 450014695$IPR016374:Transcription factor, GATA-1/2/3]
GATA binding protein 3,OMIM_DISEASE[520002530$Hypoparathyroidism, sensorineural deafness, and renal dysplasia]
GATA binding protein 3,PIR_SUPERFAMILY[630003115$PIRSF003027:TF_GATA-1/2/3]
GATA binding protein 3,SMART[760000352$SM00401:ZnF_GATA]
GATA binding protein 3,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
GATA binding protein 3,UP_SEQ_FEATURE[850064903$chain:Trans-acting T-cell-specific transcription factor GATA-3, 850102581$compositionally biased region:Poly-Ser, 850102582$compositionally biased region:Poly-Thr, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118823$zinc finger region:GATA-type 1, 850118824$zinc finger region:GATA-type 2]
GTP cyclohydrolase I feedback regulator,INTERPRO[450008232$IPR009112:GTP cyclohydrolase I, feedback regulatory protein]
GTP cyclohydrolase I feedback regulator,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000919$membrane, 790001065$nucleus]
GTP cyclohydrolase I feedback regulator,UP_SEQ_FEATURE[850022514$chain:GTP cyclohydrolase 1 feedback regulatory protein]
KIAA1683,COG_ONTOLOGY[90000053$Cytoskeleton]
KIAA1683,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region]
KIAA1683,SMART[760000009$SM00015:IQ]
KIAA1683,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
KIAA1683,UP_SEQ_FEATURE[850075562$chain:Uncharacterized protein KIAA1683, 850102605$compositionally biased region:Thr-rich, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850104473$domain:IQ 4, 850104477$domain:IQ 5, 850104478$domain:IQ 6, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Kruppel-like factor 6,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
Kruppel-like factor 6,OMIM_DISEASE[520001968$Gastric cancer, somatic, 520004116$Prostate adenocarcinoma-1, 520004129$Prostate cancer, somatic]
Kruppel-like factor 6,SMART[760000323$SM00355:ZnF_C2H2]
Kruppel-like factor 6,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
Kruppel-like factor 6,UP_SEQ_FEATURE[850027611$chain:Krueppel-like factor 6, 850117294$sequence conflict, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
Kv channel interacting protein 2,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Kv channel interacting protein 2,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
Kv channel interacting protein 2,SMART[760000046$SM00054:EFh]
Kv channel interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001304$repeat, 790001558$transport, 790001631$voltage-gated channel]
Kv channel interacting protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850027659$chain:Kv channel-interacting protein 2, 850103582$domain:EF-hand 1; degenerate, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112463$region of interest:Interaction with KCND2, 850117294$sequence conflict, 850118574$splice variant]
LBXCOR1 homolog (mouse),INTERPRO[450002951$IPR003380:Transforming protein Ski, 450009947$IPR010919:SAND-like, 450013339$IPR014890:c-SKI Smad4 binding]
LBXCOR1 homolog (mouse),OMIM_DISEASE[520002018$Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions]
LBXCOR1 homolog (mouse),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
LBXCOR1 homolog (mouse),UP_SEQ_FEATURE[850027897$chain:Ladybird homeobox corepressor 1, 850118574$splice variant]
MACRO domain containing 1,INTERPRO[450002300$IPR002589:Appr-1-p processing]
MACRO domain containing 1,SMART[760000449$SM00506:A1pp]
MACRO domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000316$chromosomal rearrangement, 790000356$complete proteome]
MACRO domain containing 1,UP_SEQ_FEATURE[850029466$chain:MACRO domain-containing protein 1, 850104739$domain:Macro, 850106258$modified residue, 850117936$site:Breakpoint for translocation to form RUNX1-MACROD1]
MAP7 domain containing 1,INTERPRO[450007865$IPR008604:E-MAP-115]
MAP7 domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000811$isopeptide bond, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
MAP7 domain containing 1,UP_SEQ_FEATURE[850030508$chain:MAP7 domain-containing protein 1, 850102586$compositionally biased region:Pro-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),COG_ONTOLOGY[90000008$Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),INTERPRO[450001969$IPR002220:Dihydrodipicolinate synthetase, 450012397$IPR013785:Aldolase-type TIM barrel]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000407$cytoplasm, 790000891$lyase, 790001357$Schiff base]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),UP_SEQ_FEATURE[850000152$active site:Schiff-base intermediate with substrate, 850033220$chain:N-acetylneuraminate lyase, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850118380$site:Involved in proton transfer during cleavage, 850118574$splice variant]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,INTERPRO[450006227$IPR006823:Neutral/alkaline nonlysosomal ceramidase]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,KEGG_PATHWAY[470038783$hsa00600:Sphingolipid metabolism]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,PIR_SUPERFAMILY[630007339$PIRSF007540:neutral/alkaline ceramidase]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000873$lipid metabolism, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001409$Signal-anchor, 790001428$sphingolipid metabolism, 790001555$transmembrane, 790001592$ubl conjugation]
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C; N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850034152$chain:Neutral ceramidase, 850034153$chain:Neutral ceramidase soluble form, 850051630$chain:Putative inactive neutral ceramidase B, 850052910$chain:Putative neutral ceramidase C, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106259$mutagenesis site, 850114274$region of interest:Required for correct folding and localization, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
OTU domain containing 3,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain]
OTU domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
OTU domain containing 3,UP_SEQ_FEATURE[850036298$chain:OTU domain-containing protein 3, 850104870$domain:OTU, 850106258$modified residue, 850117295$sequence variant]
OTU domain, ubiquitin aldehyde binding 2,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain, 450014937$IPR016615:Ubiquitin thioesterase Otubain, 450017638$IPR019400:Peptidase C65, otubain]
OTU domain, ubiquitin aldehyde binding 2,PIR_SUPERFAMILY[630011258$PIRSF013503:ubiquitin thioesterase Otubain, 630011259$PIRSF013503:Ubiquitin_thioesterase_Otubain]
OTU domain, ubiquitin aldehyde binding 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
OTU domain, ubiquitin aldehyde binding 2,UP_SEQ_FEATURE[850068042$chain:Ubiquitin thioesterase OTUB2, 850104870$domain:OTU, 850105852$helix, 850106259$mutagenesis site, 850118547$site:Required to orient and stabilize the active site H-224, 850118574$splice variant, 850118575$strand]
PDZ domain containing 8,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding]
PDZ domain containing 8,SMART[760000096$SM00109:C1, 760000200$SM00228:PDZ]
PDZ domain containing 8,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
PDZ domain containing 8,UP_SEQ_FEATURE[850036988$chain:PDZ domain-containing protein 8, 850102586$compositionally biased region:Pro-rich, 850104918$domain:PDZ, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
POU class 3 homeobox 1,INTERPRO[450000280$IPR000327:POU-specific, 450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450012446$IPR013847:POU, 450016278$IPR017970:Homeobox, conserved site]
POU class 3 homeobox 1,PIR_SUPERFAMILY[630002737$PIRSF002629:POU domain class 3 transcription factor, brain type]
POU class 3 homeobox 1,SMART[760000320$SM00352:POU, 760000341$SM00389:HOX]
POU class 3 homeobox 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
POU class 3 homeobox 1,UP_SEQ_FEATURE[850040239$chain:POU domain, class 3, transcription factor 1, 850102378$compositionally biased region:Ala-rich, 850102517$compositionally biased region:Gly-rich, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850102574$compositionally biased region:Poly-His, 850102580$compositionally biased region:Poly-Pro, 850102927$DNA-binding region:Homeobox, 850105054$domain:POU-specific, 850117294$sequence conflict]
PR domain containing 11,INTERPRO[450001068$IPR001214:SET]
PR domain containing 11,SMART[760000286$SM00317:SET]
PR domain containing 11,SP_PIR_KEYWORDS[790000356$complete proteome]
PR domain containing 11,UP_SEQ_FEATURE[850040296$chain:PR domain-containing protein 11, 850105340$domain:SET]
REST corepressor 1,INTERPRO[450000828$IPR000949:ELM2, 450000876$IPR001005:SANT, DNA-binding, 450013228$IPR014778:Myb, DNA-binding, 450016201$IPR017884:SANT, eukarya]
REST corepressor 1,KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
REST corepressor 1,SMART[760000623$SM00717:SANT]
REST corepressor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
REST corepressor 1,UP_SEQ_FEATURE[850057312$chain:REST corepressor 1, 850102378$compositionally biased region:Ala-rich, 850103712$domain:ELM2, 850105255$domain:SANT 1, 850105256$domain:SANT 2, 850105852$helix, 850106258$modified residue, 850112389$region of interest:Interaction with HDAC1, 850112495$region of interest:Interaction with LSD1, 850118624$turn]
RNA binding motif protein 19,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
RNA binding motif protein 19,SMART[760000328$SM00360:RRM]
RNA binding motif protein 19,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
RNA binding motif protein 19,UP_SEQ_FEATURE[850043647$chain:Probable RNA-binding protein 19, 850102572$compositionally biased region:Poly-Glu, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105216$domain:RRM 4, 850105217$domain:RRM 5, 850105218$domain:RRM 6, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
RNA binding motif protein 34,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
RNA binding motif protein 34,SMART[760000328$SM00360:RRM]
RNA binding motif protein 34,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
RNA binding motif protein 34,UP_SEQ_FEATURE[850058486$chain:RNA-binding protein 34, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
S100 calcium binding protein A16,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A16,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat]
S100 calcium binding protein A16,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047559$chain:Protein S100-A16, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106258$modified residue]
S100 calcium binding protein A6,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
S100 calcium binding protein A6,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A6,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000211$calcium, 790000212$calcium binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000480$EF hand, 790000635$growth regulation, 790000919$membrane, 790000937$metal-binding, 790000972$mitogen, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat]
S100 calcium binding protein A6,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850047564$chain:Protein S100-A6, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SCAN domain containing 2 pseudogene,INTERPRO[450002887$IPR003309:Transcriptional regulator SCAN]
SCAN domain containing 2 pseudogene,SMART[760000377$SM00431:SCAN]
SCAN domain containing 2 pseudogene,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
SCAN domain containing 2 pseudogene,UP_SEQ_FEATURE[850058938$chain:SCAN domain-containing protein 2, 850102378$compositionally biased region:Ala-rich, 850102404$compositionally biased region:Arg-rich, 850105271$domain:SCAN box, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SEC11 homolog A (S. cerevisiae),INTERPRO[450001536$IPR001733:Peptidase S26B, eukaryotic signal peptidase, 450017991$IPR019756:Peptidase S26A, signal peptidase I, serine active site, 450017993$IPR019758:Peptidase S26A, signal peptidase I, conserved site, 450017994$IPR019759:Peptidase S24, S26A and S26B, conserved region]
SEC11 homolog A (S. cerevisiae),PIR_SUPERFAMILY[630001349$PIRSF001209:signal peptidase SEC11]
SEC11 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790000959$microsome, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane]
SEC11 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850060748$chain:Signal peptidase complex catalytic subunit SEC11A, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
SLIT-ROBO Rho GTPase activating protein 1,INTERPRO[450000169$IPR000198:RhoGAP, 450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain]
SLIT-ROBO Rho GTPase activating protein 1,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
SLIT-ROBO Rho GTPase activating protein 1,SMART[760000047$SM00055:FCH, 760000293$SM00324:RhoGAP, 760000295$SM00326:SH3]
SLIT-ROBO Rho GTPase activating protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001398$sh3 domain]
SLIT-ROBO Rho GTPase activating protein 1,UP_SEQ_FEATURE[850060966$chain:SLIT-ROBO Rho GTPase-activating protein 1, 850102566$compositionally biased region:Poly-Arg, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850103755$domain:FCH, 850105183$domain:Rho-GAP, 850105350$domain:SH3, 850106258$modified residue, 850118574$splice variant]
STE20-like kinase (yeast),INTERPRO[450000618$IPR000719:Protein kinase, core, 450001719$IPR001943:UvrB/UvrC protein, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
STE20-like kinase (yeast),KEGG_PATHWAY[470038835$hsa04114:Oocyte meiosis]
STE20-like kinase (yeast),SMART[760000193$SM00220:S_TKc]
STE20-like kinase (yeast),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
STE20-like kinase (yeast),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850062406$chain:STE20-like serine/threonine-protein kinase, 850102507$compositionally biased region:Glu-rich, 850102577$compositionally biased region:Poly-Lys, 850105086$domain:Protein kinase, 850105615$domain:UVR, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118020$site:Cleavage; by caspase-3, 850118574$splice variant, 850118575$strand, 850118624$turn]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,COG_ONTOLOGY[90000115$Transcription]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,INTERPRO[450004306$IPR004823:TATA box binding protein associated factor (TAF), 450008207$IPR009072:Histone-fold, 450010308$IPR011442:Protein of unknown function DUF1546]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,SMART[760000706$SM00803:TAF]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa,UP_SEQ_FEATURE[850063463$chain:TAF6-like RNA polymerase II p300/CBP- associated factor-associated factor 65 kDa subunit 6L, 850106258$modified residue]
TAP binding protein-like,INTERPRO[450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450003158$IPR003597:Immunoglobulin C1-set, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450007393$IPR008056:Tapasin, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
TAP binding protein-like,SMART[760000355$SM00407:IGc1, 760000357$SM00409:IG]
TAP binding protein-like,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000768$Immunoglobulin domain, 790000919$membrane, 790000959$microsome, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
TAP binding protein-like,UP_SEQ_FEATURE[850063523$chain:Tapasin-related protein, 850102883$disulfide bond, 850104352$domain:Ig-like C1-type, 850104407$domain:Ig-like V-type, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
TIMELESS interacting protein,INTERPRO[450011599$IPR012923:Replication fork protection component Swi3]
TIMELESS interacting protein,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
TIMELESS interacting protein,UP_SEQ_FEATURE[850064497$chain:TIMELESS-interacting protein, 850106258$modified residue, 850112949$region of interest:Interaction with TIMELESS, 850117294$sequence conflict, 850117295$sequence variant]
UEV and lactate/malate dehyrogenase domains,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450001087$IPR001236:Lactate/malate dehydrogenase, 450001383$IPR001557:L-lactate/malate dehydrogenase, 450008125$IPR008883:Tumour susceptibility gene 101, 450014366$IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal, 450014426$IPR016040:NAD(P)-binding domain, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
UEV and lactate/malate dehyrogenase domains,PIR_SUPERFAMILY[630000119$PIRSF000102:Lac_mal_DH]
UEV and lactate/malate dehyrogenase domains,SMART[760000185$SM00212:UBCc]
UEV and lactate/malate dehyrogenase domains,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001006$nad, 790001593$ubl conjugation pathway]
UEV and lactate/malate dehyrogenase domains,UP_SEQ_FEATURE[850068113$chain:Ubiquitin-conjugating enzyme E2 variant 3, 850105607$domain:UEV, 850105852$helix, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
WAS protein family, member 2,BIOCARTA[30000006$h_actinYPathway:Y branching of actin filaments]
WAS protein family, member 2,INTERPRO[450002748$IPR003124:Actin-binding WH2, 450003503$IPR003980:Histamine H3 receptor]
WAS protein family, member 2,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton]
WAS protein family, member 2,PIR_SUPERFAMILY[630030009$PIRSF038481:Wiskott-Aldrich syndrome proteins]
WAS protein family, member 2,SMART[760000218$SM00246:WH2]
WAS protein family, member 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein]
WAS protein family, member 2,UP_SEQ_FEATURE[850100902$chain:Wiskott-Aldrich syndrome protein family member 2, 850102580$compositionally biased region:Poly-Pro, 850105698$domain:WH2, 850105852$helix, 850106258$modified residue]
WD repeat domain 26,INTERPRO[450001490$IPR001680:WD40 repeat, 450006014$IPR006594:LisH dimerisation motif, 450006015$IPR006595:CTLH, C-terminal to LisH motif, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 26,SMART[760000289$SM00320:WD40, 760000580$SM00667:LisH, 760000581$SM00668:CTLH]
WD repeat domain 26,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 26,UP_SEQ_FEATURE[850100732$chain:WD repeat-containing protein 26, 850103431$domain:CTLH, 850104733$domain:LisH, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850118574$splice variant]
WD repeat domain 37,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 37,SMART[760000289$SM00320:WD40]
WD repeat domain 37,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 37,UP_SEQ_FEATURE[850100741$chain:WD repeat-containing protein 37, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),INTERPRO[450002899$IPR003323:Ovarian tumour, otubain, 450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),KEGG_PATHWAY[470038804$hsa00903:Limonene and pinene degradation, 470038811$hsa01040:Biosynthesis of unsaturated fatty acids]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),SMART[760000323$SM00355:ZnF_C2H2]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway, 790001595$unfolded protein response, 790001648$zinc, 790001651$zinc-finger]
YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850068040$chain:Ubiquitin thioesterase OTU1, 850104870$domain:OTU, 850106259$mutagenesis site, 850114999$region of interest:UBX-like, 850117294$sequence conflict, 850118574$splice variant, 850118655$zinc finger region:C2H2-type]
adenylate kinase 7,COG_ONTOLOGY[90000033$Cell envelope biogenesis, outer membrane / Carbohydrate transport and metabolism]
adenylate kinase 7,INTERPRO[450000742$IPR000850:Adenylate kinase, 450007206$IPR007858:Dpy-30, conserved site]
adenylate kinase 7,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenylate kinase 7,SP_PIR_KEYWORDS[790000138$atp-binding, 790000322$cilium biogenesis/degradation, 790000344$coiled coil, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001547$transferase]
adenylate kinase 7,UP_SEQ_FEATURE[850049315$chain:Putative adenylate kinase 7, 850102507$compositionally biased region:Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850106263$nucleotide phosphate-binding region:ATP, 850110876$region of interest:Adenylate kinase, 850111538$region of interest:DPY-30, 850117294$sequence conflict, 850117295$sequence variant]
adherens junctions associated protein 1,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
adherens junctions associated protein 1,UP_SEQ_FEATURE[850003944$chain:Adherens junction-associated protein 1, 850102605$compositionally biased region:Thr-rich, 850106258$modified residue, 850106259$mutagenesis site, 850114851$region of interest:Targeting signals, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
adhesion molecule with Ig-like domain 1,COG_ONTOLOGY[90000070$Function unknown]
adhesion molecule with Ig-like domain 1,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin]
adhesion molecule with Ig-like domain 1,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000357$SM00409:IG]
adhesion molecule with Ig-like domain 1,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000267$cell projection, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001016$neurogenesis, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
adhesion molecule with Ig-like domain 1,UP_SEQ_FEATURE[850005152$chain:Amphoterin-induced protein 1, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
aldehyde dehydrogenase 18 family, member A1,INTERPRO[450000838$IPR000965:Gamma-glutamyl phosphate reductase GPR, 450000919$IPR001048:Aspartate/glutamate/uridylate kinase, 450000926$IPR001057:Glutamate 5-kinase, 450005170$IPR005715:Glutamate 5-kinase, ProB-related, 450005220$IPR005766:Delta l-pyrroline-5-carboxylate synthetase, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal, 450014511$IPR016163:Aldehyde dehydrogenase, C-terminal, 450018029$IPR019797:Glutamate 5-kinase, conserved site]
aldehyde dehydrogenase 18 family, member A1,KEGG_PATHWAY[470038752$hsa00330:Arginine and proline metabolism]
aldehyde dehydrogenase 18 family, member A1,OMIM_DISEASE[520002405$Hyperammonemia with hypoornithinemia, hypocitrullinemia, hypoargininemia, and hypoprolinemia, 520003171$Mental retardation, joint hypermobility and skin laxity, with or without metabolic abnormalities]
aldehyde dehydrogenase 18 family, member A1,PIR_SUPERFAMILY[630027876$PIRSF036429:Delta-1-pyrroline-5-carboxylate synthetase, 630027877$PIRSF036429:P5C_syn]
aldehyde dehydrogenase 18 family, member A1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000064$amino-acid biosynthesis, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000825$kinase, 790000919$membrane, 790000930$mental retardation, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790000993$multifunctional enzyme, 790001008$nadp, 790001063$nucleotide-binding, 790001092$oxidoreductase, 790001212$polymorphism, 790001246$proline biosynthesis, 790001547$transferase]
aldehyde dehydrogenase 18 family, member A1,UP_SEQ_FEATURE[850014775$chain:Delta-1-pyrroline-5-carboxylate synthetase, 850105852$helix, 850111736$region of interest:Gamma-glutamyl phosphate reductase, 850111775$region of interest:Glutamate 5-kinase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
aldo-keto reductase family 1, member A1 (aldehyde reductase),INTERPRO[450001240$IPR001395:Aldo/keto reductase, 450016460$IPR018170:Aldo/keto reductase, conserved site]
aldo-keto reductase family 1, member A1 (aldehyde reductase),KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038775$hsa00561:Glycerolipid metabolism]
aldo-keto reductase family 1, member A1 (aldehyde reductase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism]
aldo-keto reductase family 1, member A1 (aldehyde reductase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000555$binding site:Substrate, 850004303$chain:Alcohol dehydrogenase [NADP+], 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118575$strand]
aldo-keto reductase family 7-like,INTERPRO[450001240$IPR001395:Aldo/keto reductase]
aldo-keto reductase family 7-like,PIR_SUPERFAMILY[630000111$PIRSF000097:aldo-keto reductase]
aldo-keto reductase family 7-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001368$selenium, 790001370$selenocysteine]
aldo-keto reductase family 7-like,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000461$binding site:NADP, 850000555$binding site:Substrate, 850004121$chain:Aflatoxin B1 aldehyde reductase member 4, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118574$splice variant]
angiomotin like 1,INTERPRO[450008234$IPR009114:Angiomotin]
angiomotin like 1,KEGG_PATHWAY[470038857$hsa04530:Tight junction]
angiomotin like 1,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
angiomotin like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
angiomotin like 1,UP_SEQ_FEATURE[850005272$chain:Angiomotin-like protein 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117634$short sequence motif:PDZ-binding, 850118574$splice variant]
ankyrin repeat and SOCS box-containing 2,INTERPRO[450001330$IPR001496:SOCS protein, C-terminal, 450001870$IPR002110:Ankyrin]
ankyrin repeat and SOCS box-containing 2,SMART[760000220$SM00248:ANK, 760000225$SM00253:SOCS]
ankyrin repeat and SOCS box-containing 2,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
ankyrin repeat and SOCS box-containing 2,UP_SEQ_FEATURE[850005349$chain:Ankyrin repeat and SOCS box protein 2, 850105375$domain:SOCS box, 850106259$mutagenesis site, 850115632$repeat:ANK 1, 850115633$repeat:ANK 10, 850115634$repeat:ANK 11, 850115635$repeat:ANK 12, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117294$sequence conflict, 850117295$sequence variant]
ankyrin repeat domain 34A,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 34A,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 34A,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001304$repeat]
ankyrin repeat domain 34A,UP_SEQ_FEATURE[850005392$chain:Ankyrin repeat domain-containing protein 34A, 850102586$compositionally biased region:Pro-rich, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4]
arginine vasopressin receptor 1B,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000536$IPR000628:Vasopressin VIB receptor, 450001610$IPR001817:Vasopressin receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
arginine vasopressin receptor 1B,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038845$hsa04270:Vascular smooth muscle contraction]
arginine vasopressin receptor 1B,PIR_SUPERFAMILY[630001980$PIRSF001841:vasopressin/oxytocin receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
arginine vasopressin receptor 1B,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
arginine vasopressin receptor 1B,UP_SEQ_FEATURE[850100090$chain:Vasopressin V1b receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
arginine vasopressin-induced 1,SP_PIR_KEYWORDS[790000258$cell cycle, 790000356$complete proteome, 790001212$polymorphism]
arginine vasopressin-induced 1,UP_SEQ_FEATURE[850006076$chain:Arginine vasopressin-induced protein 1, 850117294$sequence conflict, 850117295$sequence variant]
arsenic (+3 oxidation state) methyltransferase,INTERPRO[450011853$IPR013216:Methyltransferase type 11]
arsenic (+3 oxidation state) methyltransferase,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000954$methyltransferase, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001547$transferase]
arsenic (+3 oxidation state) methyltransferase,UP_SEQ_FEATURE[850006173$chain:Arsenite methyltransferase, 850117294$sequence conflict, 850117295$sequence variant]
basic leucine zipper transcription factor, ATF-like,INTERPRO[450000729$IPR000837:Fos transforming protein, 450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
basic leucine zipper transcription factor, ATF-like,SMART[760000306$SM00338:BRLZ]
basic leucine zipper transcription factor, ATF-like,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
basic leucine zipper transcription factor, ATF-like,UP_SEQ_FEATURE[850007377$chain:Basic leucine zipper transcriptional factor ATF-like, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper]
beta-1,4-N-acetyl-galactosaminyl transferase 3,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase, 450010486$IPR011658:PA14]
beta-1,4-N-acetyl-galactosaminyl transferase 3,SMART[760000664$SM00758:PA14]
beta-1,4-N-acetyl-galactosaminyl transferase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
beta-1,4-N-acetyl-galactosaminyl transferase 3,UP_SEQ_FEATURE[850033163$chain:N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
breast cancer metastasis-suppressor 1-like,INTERPRO[450012503$IPR013907:Sds3-like]
breast cancer metastasis-suppressor 1-like,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000635$growth regulation, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
breast cancer metastasis-suppressor 1-like,UP_SEQ_FEATURE[850008358$chain:Breast cancer metastasis-suppressor 1- like protein, 850117294$sequence conflict]
catenin (cadherin-associated protein), delta 1,INTERPRO[450000194$IPR000225:Armadillo, 450010814$IPR011989:Armadillo-like helical]
catenin (cadherin-associated protein), delta 1,KEGG_PATHWAY[470038856$hsa04520:Adherens junction, 470038873$hsa04670:Leukocyte transendothelial migration]
catenin (cadherin-associated protein), delta 1,SMART[760000159$SM00185:ARM]
catenin (cadherin-associated protein), delta 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001642$wnt signaling pathway]
catenin (cadherin-associated protein), delta 1,UP_SEQ_FEATURE[850009899$chain:Catenin delta-1, 850106258$modified residue, 850115674$repeat:ARM 1, 850115675$repeat:ARM 10, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850115689$repeat:ARM 7, 850115690$repeat:ARM 8, 850115691$repeat:ARM 9, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
chaperonin containing TCP1, subunit 3 (gamma),INTERPRO[450001946$IPR002194:Chaperonin TCP-1, conserved site, 450002152$IPR002423:Chaperonin Cpn60/TCP-1, 450011398$IPR012719:T-complex protein 1, gamma subunit, 450016306$IPR017998:Chaperone, tailless complex polypeptide 1]
chaperonin containing TCP1, subunit 3 (gamma),PIR_SUPERFAMILY[630002698$PIRSF002584:molecular chaperone t-complex-type]
chaperonin containing TCP1, subunit 3 (gamma),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000976$molecular chaperone, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
chaperonin containing TCP1, subunit 3 (gamma),UP_SEQ_FEATURE[850063420$chain:T-complex protein 1 subunit gamma, 850102883$disulfide bond, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 1 open reading frame 110,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome]
chromosome 1 open reading frame 110,UP_SEQ_FEATURE[850012083$chain:Coiled-coil domain-containing protein C1orf110, 850117294$sequence conflict, 850118574$splice variant]
chromosome 1 open reading frame 116,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001301$receptor]
chromosome 1 open reading frame 116,UP_SEQ_FEATURE[850061756$chain:Specifically androgen-regulated gene protein, 850102378$compositionally biased region:Ala-rich, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 168,INTERPRO[450001294$IPR001452:Src homology-3 domain]
chromosome 1 open reading frame 168,SMART[760000295$SM00326:SH3]
chromosome 1 open reading frame 168,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 168,UP_SEQ_FEATURE[850073612$chain:Uncharacterized protein C1orf168, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 38,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 38,UP_SEQ_FEATURE[850047978$chain:Protein THEMIS2, 850102462$compositionally biased region:Asp/Glu-rich, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 56,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001363$Secreted, 790001405$signal]
chromosome 1 open reading frame 56,UP_SEQ_FEATURE[850073664$chain:Uncharacterized protein C1orf56, 850106258$modified residue, 850117814$signal peptide, 850118574$splice variant]
chromosome 1 open reading frame 86,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 86,UP_SEQ_FEATURE[850073673$chain:Uncharacterized protein C1orf86, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 88,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 88,UP_SEQ_FEATURE[850073677$chain:Uncharacterized protein C1orf88, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 10 open reading frame 118,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 10 open reading frame 118,UP_SEQ_FEATURE[850072893$chain:Uncharacterized protein C10orf118, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 10 open reading frame 137,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001539$Transcription, 790001543$transcription regulation]
chromosome 10 open reading frame 137,UP_SEQ_FEATURE[850017806$chain:Erythroid differentiation-related factor 1, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 10 open reading frame 46,INTERPRO[450001217$IPR001373:Cullin, N-terminal, 450001218$IPR001373:Cullin, N-terminal region, 450014507$IPR016157:Cullin, conserved site]
chromosome 10 open reading frame 46,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 10 open reading frame 46,UP_SEQ_FEATURE[850072903$chain:Uncharacterized protein C10orf46, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
chromosome 11 open reading frame 80,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
chromosome 11 open reading frame 80,UP_SEQ_FEATURE[850055199$chain:Putative uncharacterized protein C11orf80, 850118574$splice variant]
chromosome 11 open reading frame 87,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
chromosome 11 open reading frame 87,UP_SEQ_FEATURE[850072999$chain:Uncharacterized protein C11orf87, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 12 open reading frame 51,INTERPRO[450000485$IPR000569:HECT]
chromosome 12 open reading frame 51,SMART[760000104$SM00119:HECTc]
chromosome 12 open reading frame 51,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000853$leucine-rich repeat, 790000859$ligase, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane, 790001593$ubl conjugation pathway]
chromosome 12 open reading frame 51,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850041861$chain:Probable E3 ubiquitin-protein ligase KIAA0614, 850066253$chain:Transmembrane protein C12orf51, 850102565$compositionally biased region:Poly-Ala, 850102568$compositionally biased region:Poly-Asp, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850104105$domain:HECT, 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
chromosome 12 open reading frame 52,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 12 open reading frame 52,UP_SEQ_FEATURE[850073056$chain:Uncharacterized protein C12orf52, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 12 open reading frame 57,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome]
chromosome 12 open reading frame 57,UP_SEQ_FEATURE[850045288$chain:Protein C10, 850106258$modified residue]
chromosome 14 open reading frame 102,INTERPRO[450012256$IPR013633:Protein of unknown function DUF1740]
chromosome 14 open reading frame 102,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
chromosome 14 open reading frame 102,UP_SEQ_FEATURE[850097951$chain:UPF0614 protein C14orf102, 850102554$compositionally biased region:Lys-rich, 850102577$compositionally biased region:Poly-Lys, 850102581$compositionally biased region:Poly-Ser, 850116114$repeat:HAT 1, 850116123$repeat:HAT 2, 850116124$repeat:HAT 3, 850116125$repeat:HAT 4, 850116126$repeat:HAT 5, 850117295$sequence variant]
chromosome 14 open reading frame 159,INTERPRO[450008991$IPR009906:Protein of unknown function DUF1445, 450015455$IPR017135:Uncharacterised protein family UPF0317, mitochondria]
chromosome 14 open reading frame 159,PIR_SUPERFAMILY[630028722$PIRSF037204:UCP037204, 630028723$PIRSF037204:uncharacterized conserved protein]
chromosome 14 open reading frame 159,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism, 790001550$transit peptide]
chromosome 14 open reading frame 159,UP_SEQ_FEATURE[850094009$chain:UPF0317 protein C14orf159, mitochondrial, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
chromosome 19 open reading frame 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 19 open reading frame 12,UP_SEQ_FEATURE[850073499$chain:Uncharacterized protein C19orf12, 850118574$splice variant, 850118623$transmembrane region]
coenzyme Q10 homolog A (S. cerevisiae),INTERPRO[450004501$IPR005031:Streptomyces cyclase/dehydrase]
coenzyme Q10 homolog A (S. cerevisiae),PIR_SUPERFAMILY[630012786$PIRSF016012:uncharacterized protein with polyketide synthase domain]
coenzyme Q10 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001550$transit peptide]
coenzyme Q10 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850011898$chain:Coenzyme Q-binding protein COQ10 homolog A, mitochondrial, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
coiled-coil domain containing 85B,INTERPRO[450017597$IPR019359:Protein of unknown function DUF2216]
coiled-coil domain containing 85B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000434$differentiation, 790000635$growth regulation, 790001065$nucleus, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
coiled-coil domain containing 85B,UP_SEQ_FEATURE[850012063$chain:Coiled-coil domain-containing protein 85B, 850106259$mutagenesis site, 850117294$sequence conflict]
coiled-coil domain containing 92,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 92,UP_SEQ_FEATURE[850012075$chain:Coiled-coil domain-containing protein 92, 850106258$modified residue, 850117295$sequence variant]
colipase, pancreatic,INTERPRO[450001754$IPR001981:Colipase, 450016227$IPR017913:Colipase, N-terminal, 450016228$IPR017914:Colipase, C-terminal, 450016229$IPR017915:Colipase, conserved site, 450016400$IPR018100:Colipase subgroup]
colipase, pancreatic,PIR_SUPERFAMILY[630002535$PIRSF002415:colipase]
colipase, pancreatic,SMART[760000016$SM00023:COLIPASE]
colipase, pancreatic,SP_PIR_KEYWORDS[790000356$complete proteome, 790000430$diabetes mellitus, 790000435$digestion, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000869$lipid degradation, 790000870$lipid digestion, 790000872$lipid hydrolysis, 790001102$pancreas, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
colipase, pancreatic,UP_SEQ_FEATURE[850012167$chain:Colipase, 850102883$disulfide bond, 850109658$propeptide:Enterostatin, activation peptide, 850117295$sequence variant, 850117814$signal peptide]
collagen, type IX, alpha 2,INTERPRO[450007490$IPR008160:Collagen triple helix repeat]
collagen, type IX, alpha 2,OMIM_DISEASE[520001776$Epiphyseal dysplasia, multiple, 2, 520002663$Intervertebral disc disease, susceptibility to]
collagen, type IX, alpha 2,PIR_SUPERFAMILY[630003587$PIRSF003543:human herpesvirus 4 BHLF1 protein]
collagen, type IX, alpha 2,SP_PIR_KEYWORDS[790000308$chondroitin sulfate proteoglycan, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000474$dwarfism, 790000530$extracellular matrix, 790000616$glycoprotein, 790000687$heterotrimer, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001568$triple helix]
collagen, type IX, alpha 2,UP_SEQ_FEATURE[850012205$chain:Collagen alpha-2(IX) chain, 850102883$disulfide bond, 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850113771$region of interest:Nonhelical region 1 (NC1), 850113774$region of interest:Nonhelical region 2 (NC2), 850113775$region of interest:Nonhelical region 3 (NC3), 850113776$region of interest:Nonhelical region 4 (NC4), 850114944$region of interest:Triple-helical region 1 (COL1), 850114949$region of interest:Triple-helical region 2 (COL2), 850114951$region of interest:Triple-helical region 3 (COL3), 850114952$region of interest:Triple-helical region 4 (COL4), 850117295$sequence variant, 850117814$signal peptide]
crumbs homolog 3 (Drosophila),KEGG_PATHWAY[470038857$hsa04530:Tight junction]
crumbs homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001528$Tight junction, 790001555$transmembrane]
crumbs homolog 3 (Drosophila),UP_SEQ_FEATURE[850012741$chain:Crumbs protein homolog 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117634$short sequence motif:PDZ-binding, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cyclin B1 interacting protein 1,INTERPRO[450016222$IPR017907:Zinc finger, RING-type, conserved site]
cyclin B1 interacting protein 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000859$ligase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
cyclin B1 interacting protein 1,UP_SEQ_FEATURE[850016625$chain:E3 ubiquitin-protein ligase CCNB1IP1, 850106259$mutagenesis site, 850118919$zinc finger region:RING-type; atypical]
cyclin J,INTERPRO[450003872$IPR004367:Cyclin, C-terminal, 450006082$IPR006670:Cyclin, 450006083$IPR006671:Cyclin, N-terminal, 450012382$IPR013763:Cyclin-related]
cyclin J,SMART[760000337$SM00385:CYCLIN]
cyclin J,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000389$cyclin]
cyclin J,UP_SEQ_FEATURE[850013129$chain:Cyclin-J, 850103467$domain:Cyclin N-terminal, 850118574$splice variant]
cyclin-dependent kinase 2 associated protein 2,INTERPRO[450015588$IPR017266:Cyclin-dependent kinase 2-associated protein 2, 450017433$IPR019187:Cyclin-dependent kinase 2-associated protein]
cyclin-dependent kinase 2 associated protein 2,PIR_SUPERFAMILY[630029280$PIRSF037709:CDK2-associated_p2, 630029281$PIRSF037709:cyclin-dependent kinase 2-associated protein 2]
cyclin-dependent kinase 2 associated protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000825$kinase]
cyclin-dependent kinase 2 associated protein 2,UP_SEQ_FEATURE[850013068$chain:Cyclin-dependent kinase 2-associated protein 2]
cysteine and histidine-rich domain (CHORD)-containing 1; cysteine and histidine-rich domain (CHORD)-containing 1 pseudogene,INTERPRO[450006445$IPR007051:CHORD, 450006446$IPR007052:CS domain, 450015774$IPR017447:CS]
cysteine and histidine-rich domain (CHORD)-containing 1; cysteine and histidine-rich domain (CHORD)-containing 1 pseudogene,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
cysteine and histidine-rich domain (CHORD)-containing 1; cysteine and histidine-rich domain (CHORD)-containing 1 pseudogene,UP_SEQ_FEATURE[850013240$chain:Cysteine and histidine-rich domain- containing protein 1, 850103353$domain:CHORD 1, 850103354$domain:CHORD 2, 850103417$domain:CS, 850105852$helix, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106235$metal ion-binding site:Zinc 3, 850106236$metal ion-binding site:Zinc 4, 850106258$modified residue, 850112424$region of interest:Interaction with HSP90AA1 and HSP90AB1, 850112705$region of interest:Interaction with PPP5C, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cysteine-rich with EGF-like domains 1,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450005636$IPR006210:EGF-like, 450005638$IPR006212:Furin-like repeat, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
cysteine-rich with EGF-like domains 1,OMIM_DISEASE[520000460$Atrioventricular septal defect, partial, with heterotaxy syndrome, 520000461$Atrioventricular septal defect, susceptibility to, 2]
cysteine-rich with EGF-like domains 1,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF, 760000233$SM00261:FU]
cysteine-rich with EGF-like domains 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
cysteine-rich with EGF-like domains 1,UP_SEQ_FEATURE[850013392$chain:Cysteine-rich with EGF-like domain protein 1, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850116009$repeat:FU 1, 850116015$repeat:FU 2, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
cytochrome b5 reductase-like,INTERPRO[450001275$IPR001433:Oxidoreductase FAD/NAD(P)-binding, 450001622$IPR001834:NADH:cytochrome b5 reductase (CBR), 450007611$IPR008333:Oxidoreductase FAD-binding region, 450016241$IPR017927:Ferredoxin reductase-type FAD-binding domain]
cytochrome b5 reductase-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000537$FAD, 790000559$Flavoprotein, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
cytochrome b5 reductase-like,UP_SEQ_FEATURE[850033584$chain:NADH-cytochrome b5 reductase-like, 850103737$domain:FAD-binding FR-type, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118574$splice variant]
dehydrodolichyl diphosphate synthase,INTERPRO[450001283$IPR001441:Di-trans-poly-cis-decaprenylcistransferase-like, 450016792$IPR018520:Di-trans-poly-cis-decaprenylcistransferase-like, conserved site]
dehydrodolichyl diphosphate synthase,KEGG_PATHWAY[470038803$hsa00900:Terpenoid backbone biosynthesis]
dehydrodolichyl diphosphate synthase,PIR_SUPERFAMILY[630005562$PIRSF005638:cis-prenyltransferase, 630030528$PIRSF500283:dehydrodolichyl diphosphate synthase, Fungi/Metazoa type]
dehydrodolichyl diphosphate synthase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001547$transferase]
dehydrodolichyl diphosphate synthase,UP_SEQ_FEATURE[850014707$chain:Dehydrodolichyl diphosphate synthase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dehydrogenase/reductase (SDR family) member 4 like 2,INTERPRO[450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002088$IPR002347:Glucose/ribitol dehydrogenase, 450014426$IPR016040:NAD(P)-binding domain]
dehydrogenase/reductase (SDR family) member 4 like 2,KEGG_PATHWAY[470038801$hsa00830:Retinol metabolism]
dehydrogenase/reductase (SDR family) member 4 like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
dehydrogenase/reductase (SDR family) member 4 like 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850014723$chain:Dehydrogenase/reductase SDR family member 4-like 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
developmental pluripotency associated 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001212$polymorphism]
developmental pluripotency associated 3,UP_SEQ_FEATURE[850014969$chain:Developmental pluripotency-associated protein 3, 850117294$sequence conflict, 850117295$sequence variant]
dickkopf homolog 3 (Xenopus laevis),INTERPRO[450006202$IPR006796:Dickkopf, N-terminal cysteine-rich]
dickkopf homolog 3 (Xenopus laevis),PIR_SUPERFAMILY[630012236$PIRSF015386:Dickkopf-related protein 3 (Dkk-3)]
dickkopf homolog 3 (Xenopus laevis),SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001642$wnt signaling pathway]
dickkopf homolog 3 (Xenopus laevis),UP_SEQ_FEATURE[850015042$chain:Dickkopf-related protein 3, 850102565$compositionally biased region:Poly-Ala, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850111450$region of interest:DKK-type Cys-1, 850111451$region of interest:DKK-type Cys-2, 850117295$sequence variant, 850117814$signal peptide]
discs, large (Drosophila) homolog-associated protein 3,INTERPRO[450004495$IPR005026:Guanylate-kinase-associated protein]
discs, large (Drosophila) homolog-associated protein 3,PIR_SUPERFAMILY[630014622$PIRSF017965:disks large-associated protein 1]
discs, large (Drosophila) homolog-associated protein 3,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001475$synapse]
discs, large (Drosophila) homolog-associated protein 3,UP_SEQ_FEATURE[850015435$chain:Disks large-associated protein 3, 850102574$compositionally biased region:Poly-His, 850106258$modified residue]
dynamin binding protein,BIOCARTA[30000194$h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors]
dynamin binding protein,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000189$IPR000219:Dbl homology (DH) domain, 450001173$IPR001331:Guanine-nucleotide dissociation stimulator, CDC24, conserved site, 450001294$IPR001452:Src homology-3 domain, 450003659$IPR004148:BAR, 450010373$IPR011511:Variant SH3]
dynamin binding protein,SMART[760000294$SM00325:RhoGEF, 760000295$SM00326:SH3, 760000627$SM00721:BAR]
dynamin binding protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001475$synapse]
dynamin binding protein,UP_SEQ_FEATURE[850016492$chain:Dynamin-binding protein, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850103092$domain:BAR, 850103518$domain:DH, 850105351$domain:SH3 1, 850105353$domain:SH3 2, 850105354$domain:SH3 3, 850105355$domain:SH3 4, 850105356$domain:SH3 5, 850105357$domain:SH3 6, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
dynein heavy chain domain 1,INTERPRO[450003782$IPR004273:Dynein heavy chain, 450012226$IPR013602:Dynein heavy chain, N-terminal region 2]
dynein heavy chain domain 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
dynein heavy chain domain 1,UP_SEQ_FEATURE[850016528$chain:Dynein heavy chain domain 1-like protein, 850016529$chain:Dynein heavy chain domain-containing protein 1, 850072967$chain:Uncharacterized protein C11orf47, 850102576$compositionally biased region:Poly-Leu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ecotropic viral integration site 5,INTERPRO[450000166$IPR000195:RabGAP/TBC]
ecotropic viral integration site 5,SMART[760000143$SM00164:TBC]
ecotropic viral integration site 5,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ecotropic viral integration site 5,UP_SEQ_FEATURE[850016903$chain:Ecotropic viral integration site 5 protein homolog, 850102597$compositionally biased region:Ser-rich, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850111439$region of interest:Dimerization, 850112071$region of interest:Interaction with alpha-tubulin, gamma- tubulin, BIRC5 and FBXO5, 850112112$region of interest:Interaction with AURKB and INCENP, 850114858$region of interest:Targeting to the centrosomes, 850117294$sequence conflict, 850117295$sequence variant, 850117879$site:Breakpoint for translocation to form EVI5-TRNG10 fusion protein]
endothelin converting enzyme 1,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
endothelin converting enzyme 1,INTERPRO[450000617$IPR000718:Peptidase M13, neprilysin, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450008005$IPR008753:Peptidase M13, 450016770$IPR018497:Peptidase M13, neprilysin, C-terminal]
endothelin converting enzyme 1,OMIM_DISEASE[520002339$Hirschsprung disease, cardiac defects, and autonomic dysfunction, 520002479$Hypertension, essential, susceptibility to]
endothelin converting enzyme 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000693$hirschsprung disease, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
endothelin converting enzyme 1,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850017442$chain:Endothelin-converting enzyme 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
enhancer of polycomb homolog 1 (Drosophila),INTERPRO[450008701$IPR009607:Enhancer of polycomb, C-terminal, 450017779$IPR019542:Enhancer of polycomb-like]
enhancer of polycomb homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000445$direct protein sequencing, 790000635$growth regulation, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
enhancer of polycomb homolog 1 (Drosophila),UP_SEQ_FEATURE[850017464$chain:Enhancer of polycomb homolog 1, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,INTERPRO[450001666$IPR001884:Eukaryotic initiation factor 5A hypusine (eIF-5A), 450001667$IPR001884:Translation elongation factor, IF5A, 450011038$IPR012340:Nucleic acid-binding, OB-fold, 450013174$IPR014722:Translation protein SH3-like, subgroup, 450018003$IPR019769:Eukaryotic initiation factor 5A, hypusine site, 450018004$IPR019769:Translation elongation factor, IF5A, hypusine site]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,PIR_SUPERFAMILY[630003113$PIRSF003025:eIF5A, 630003114$PIRSF003025:translation initiation factor eIF-5A]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000011$acetylated amino end, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000491$elongation factor, 790000499$endoplasmic reticulum, 790000754$hypusine, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001266$protein transport, 790001339$rna-binding, 790001554$translocation, 790001558$transport]
eukaryotic translation initiation factor 5A; eukaryotic translation initiation factor 5A-like 1,UP_SEQ_FEATURE[850018152$chain:Eukaryotic translation initiation factor 5A-1, 850018153$chain:Eukaryotic translation initiation factor 5A-1-like, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111472$region of interest:DOHH-binding, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
family with sequence similarity 101, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 101, member A,UP_SEQ_FEATURE[850045811$chain:Protein FAM101A, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 81, member A,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
family with sequence similarity 81, member A,UP_SEQ_FEATURE[850046062$chain:Protein FAM81A]
family with sequence similarity 82, member A2,INTERPRO[450010815$IPR011990:Tetratricopeptide-like helical]
family with sequence similarity 82, member A2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000434$differentiation, 790000919$membrane, 790000960$microtubule, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 82, member A2,UP_SEQ_FEATURE[850057060$chain:Regulator of microtubule dynamics protein 3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
fatty acid synthase,INTERPRO[450000688$IPR000794:Beta-ketoacyl synthase, 450000904$IPR001031:Thioesterase, 450001079$IPR001227:Acyl transferase region, 450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450005594$IPR006162:Phosphopantetheine attachment site, 450005595$IPR006163:Phosphopantetheine-binding, 450008211$IPR009081:Acyl carrier protein-like, 450011786$IPR013149:Alcohol dehydrogenase, zinc-binding, 450011854$IPR013217:Methyltransferase type 12, 450012624$IPR014030:Beta-ketoacyl synthase, N-terminal, 450012625$IPR014031:Beta-ketoacyl synthase, C-terminal, 450012635$IPR014043:Acyl transferase, 450014425$IPR016038:Thiolase-like, subgroup, 450014426$IPR016040:NAD(P)-binding domain, 450016488$IPR018201:Beta-ketoacyl synthase, active site]
fatty acid synthase,KEGG_PATHWAY[470038732$hsa00061:Fatty acid biosynthesis, 470038882$hsa04910:Insulin signaling pathway]
fatty acid synthase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000542$Fatty acid biosynthesis, 790000743$hydrolase, 790000874$lipid synthesis, 790000891$lyase, 790000993$multifunctional enzyme, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001161$Phosphopantetheine, 790001162$phosphoprotein, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
fatty acid synthase,UP_SEQ_FEATURE[850000033$active site:For beta-hydroxyacyl dehydratase activity, 850000040$active site:For beta-ketoacyl synthase activity, 850000054$active site:For malonyltransferase activity, 850000083$active site:For thioesterase activity, 850019051$chain:Fatty acid synthase, 850103010$domain:Acyl carrier, 850105852$helix, 850106258$modified residue, 850106308$nucleotide phosphate-binding region:NADP (ER), 850106309$nucleotide phosphate-binding region:NADP (KR), 850110865$region of interest:Acyl and malonyl transferases, 850111013$region of interest:Beta-ketoacyl reductase, 850111016$region of interest:Beta-ketoacyl synthase, 850111587$region of interest:Enoyl reductase, 850114875$region of interest:Thioesterase, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
filaggrin,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450002881$IPR003303:Filaggrin, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
filaggrin,OMIM_DISEASE[520000430$Atopic dermatitis, susceptibility to, 520001459$Dermatitis, atopic 2, 520001461$Dermatitis, atopic, susceptibility to, 520002581$Ichthyosis vulgaris]
filaggrin,SP_PIR_KEYWORDS[790000211$calcium, 790000212$calcium binding, 790000326$citrullination, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000445$direct protein sequencing, 790000480$EF hand, 790000506$epidermis, 790000757$Ichthyosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001484$tandem repeat]
filaggrin,UP_SEQ_FEATURE[850019469$chain:filaggrin, 850102584$compositionally biased region:Poly-Tyr, 850102597$compositionally biased region:Ser-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106258$modified residue, 850115931$repeat:Filaggrin 1, 850115932$repeat:Filaggrin 10, 850115933$repeat:Filaggrin 11, 850115934$repeat:Filaggrin 12, 850115935$repeat:Filaggrin 13, 850115936$repeat:Filaggrin 14, 850115937$repeat:Filaggrin 15, 850115938$repeat:Filaggrin 16, 850115939$repeat:Filaggrin 17, 850115940$repeat:Filaggrin 18, 850115941$repeat:Filaggrin 19, 850115942$repeat:Filaggrin 2, 850115943$repeat:Filaggrin 20, 850115944$repeat:Filaggrin 21, 850115945$repeat:Filaggrin 22, 850115946$repeat:Filaggrin 23, 850115947$repeat:Filaggrin 3, 850115948$repeat:Filaggrin 4, 850115949$repeat:Filaggrin 5, 850115950$repeat:Filaggrin 6, 850115951$repeat:Filaggrin 7, 850115952$repeat:Filaggrin 8, 850115953$repeat:Filaggrin 9, 850117294$sequence conflict, 850117295$sequence variant]
filaggrin family member 2,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450002881$IPR003303:Filaggrin, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2, 450017214$IPR018942:Seminal vesicle protein repeat]
filaggrin family member 2,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
filaggrin family member 2,UP_SEQ_FEATURE[850019470$chain:Filaggrin-2, 850102597$compositionally biased region:Ser-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850106258$modified residue, 850114567$region of interest:S-100-like, 850115931$repeat:Filaggrin 1, 850115932$repeat:Filaggrin 10, 850115942$repeat:Filaggrin 2, 850115947$repeat:Filaggrin 3, 850115948$repeat:Filaggrin 4, 850115949$repeat:Filaggrin 5, 850115950$repeat:Filaggrin 6, 850115951$repeat:Filaggrin 7, 850115952$repeat:Filaggrin 8, 850115953$repeat:Filaggrin 9, 850117295$sequence variant]
filamin binding LIM protein 1,INTERPRO[450001575$IPR001781:Zinc finger, LIM-type]
filamin binding LIM protein 1,SMART[760000114$SM00132:LIM]
filamin binding LIM protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000263$cell junction, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000864$LIM domain, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
filamin binding LIM protein 1,UP_SEQ_FEATURE[850019487$chain:Filamin-binding LIM protein 1, 850102586$compositionally biased region:Pro-rich, 850104717$domain:LIM zinc-binding 1, 850104718$domain:LIM zinc-binding 2, 850104719$domain:LIM zinc-binding 3, 850106259$mutagenesis site, 850111678$region of interest:Filamin-binding, 850114060$region of interest:PLEKHC1-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
gap junction protein, alpha 5, 40kDa,INTERPRO[450000426$IPR000500:Connexins, 450002010$IPR002264:Gap junction alpha-5 protein (Cx40), 450011736$IPR013092:Connexin, N-terminal, 450016298$IPR017990:Connexin, conserved site, 450016299$IPR017991:Connexin region, 450016300$IPR017992:Gap junction alpha-5 protein (Cx40) region, 450017807$IPR019570:Gap junction protein, cysteine-rich domain]
gap junction protein, alpha 5, 40kDa,OMIM_DISEASE[520000438$Atrial fibrillation, 520000441$Atrial fibrillation, familial 4, 520000454$Atrial standstill]
gap junction protein, alpha 5, 40kDa,PIR_SUPERFAMILY[630002418$PIRSF002292:gap junction protein]
gap junction protein, alpha 5, 40kDa,SMART[760000029$SM00037:CNX]
gap junction protein, alpha 5, 40kDa,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000581$gap junction, 790000919$membrane, 790001555$transmembrane]
gap junction protein, alpha 5, 40kDa,UP_SEQ_FEATURE[850020611$chain:Gap junction alpha-5 protein, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
germ cell associated 1,INTERPRO[450011158$IPR012478:GSG1-like]
germ cell associated 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
germ cell associated 1,UP_SEQ_FEATURE[850021091$chain:Germ cell-specific gene 1 protein, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
glucocorticoid modulatory element binding protein 1,INTERPRO[450000665$IPR000770:SAND, 450009947$IPR010919:SAND-like]
glucocorticoid modulatory element binding protein 1,SMART[760000230$SM00258:SAND]
glucocorticoid modulatory element binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc]
glucocorticoid modulatory element binding protein 1,UP_SEQ_FEATURE[850000333$binding site:DNA, 850021368$chain:Glucocorticoid modulatory element-binding protein 1, 850105253$domain:SAND, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
glucosamine (N-acetyl)-6-sulfatase,COG_ONTOLOGY[90000075$Inorganic ion transport and metabolism]
glucosamine (N-acetyl)-6-sulfatase,INTERPRO[450000800$IPR000917:Sulfatase, 450010976$IPR012251:N-acetylglucosamine-6-sulfatase, 450014386$IPR015981:N-acetylglucosamine-6-sulfatase, eukaryotic, 450016171$IPR017849:Alkaline phosphatase-like, alpha/beta/alpha]
glucosamine (N-acetyl)-6-sulfatase,KEGG_PATHWAY[470038771$hsa00531:Glycosaminoglycan degradation, 470038840$hsa04142:Lysosome]
glucosamine (N-acetyl)-6-sulfatase,OMIM_DISEASE[520003389$Mucopolysaccharidosis type IIID, 520004371$Sanfilippo disease IIID]
glucosamine (N-acetyl)-6-sulfatase,PIR_SUPERFAMILY[630028150$PIRSF036666:G6S, 630028151$PIRSF036666:N-acetylglucosamine-6-sulfatase]
glucosamine (N-acetyl)-6-sulfatase,SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000743$hydrolase, 790000896$lysosomal storage disease, 790000897$lysosome, 790000937$metal-binding, 790000992$Mucopolysaccharidosis, 790001355$Sanfilippo disease, 790001405$signal, 790001465$sulfuric ester hydrolase]
glucosamine (N-acetyl)-6-sulfatase,UP_SEQ_FEATURE[850033188$chain:N-acetylglucosamine-6-sulfatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105909$metal ion-binding site:Calcium, 850105944$metal ion-binding site:Calcium; via 3-oxoalanine, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide]
growth arrest-specific 2,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ]
growth arrest-specific 2,INTERPRO[450001520$IPR001715:Calponin-like actin-binding, 450002732$IPR003108:Growth-arrest-specific protein 2]
growth arrest-specific 2,PIR_SUPERFAMILY[630021016$PIRSF027832:PIRSF027832]
growth arrest-specific 2,SMART[760000025$SM00033:CH, 760000215$SM00243:GAS2]
growth arrest-specific 2,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000258$cell cycle, 790000268$cell shape, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000631$growth arrest, 790000919$membrane, 790001162$phosphoprotein]
growth arrest-specific 2,UP_SEQ_FEATURE[850022453$chain:Growth arrest-specific protein 2, 850103317$domain:CH, 850106258$modified residue, 850117989$site:Cleavage; by a caspase during apoptosis]
